[go: up one dir, main page]

PE20010702A1 - Proceso para la preparacion de ariloxipropanolaminas - Google Patents

Proceso para la preparacion de ariloxipropanolaminas

Info

Publication number
PE20010702A1
PE20010702A1 PE2000001222A PE0012222000A PE20010702A1 PE 20010702 A1 PE20010702 A1 PE 20010702A1 PE 2000001222 A PE2000001222 A PE 2000001222A PE 0012222000 A PE0012222000 A PE 0012222000A PE 20010702 A1 PE20010702 A1 PE 20010702A1
Authority
PE
Peru
Prior art keywords
aryloxypropanolamine
ethanol
ester
acid
mixture
Prior art date
Application number
PE2000001222A
Other languages
English (en)
Inventor
Julie Kay Bush
Steven Eugene Dunlap
Jack Wayne Fisher
John Arnold Werner
Roger Ryan Rothhaar
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of PE20010702A1 publication Critical patent/PE20010702A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/116Heterocyclic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465Nicotine; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/12Drugs for disorders of the metabolism for electrolyte homeostasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

SE REFIERE A UN METODO PARA PREPARAR UN ESTER DE ARILOXIPROPANOLAMINA DE FORMULA I, DONDE R1 ES ARILO, R2 ES ALQUILO C1-C6, ARALQUILO C7-C9; QUE COMPRENDE REACCIONAR UN EPOXIDO DE FROMULA II, R1 ES UN GRUPO A, B, DC, ENTRE OTROS; A1 Y A2 SON C, N; A3, A4 SON O, S, NH, CH2, ENTRE OTROS; n ES 1-2; R2 ES METILO, ETILO; CON UNA AMINA DE FROMULA III; REACCIONAR EL ESTER DE ARILOXIPROPANOLAMINA CON UN ACIDO (ACIDO 4-HIDROXIBENZOICO, ACIDO FTALICO, ACIDO 2-HIDROXINICOTINICO, ACIDO GLICOLICO, ENTRE OTROS); PARA FORMAR LA SAL DE AMONIO CUATERNARIO CON EL ESTER DE ARILOXIPROPANOLAMINA; CRISTALIZAR LA SAL DE AMONIO CUATERNARIO A PARTIR DE ETANOL, UNA MEZCLA DE CLOROBENCENO:ETANOL, UNA MEZCLA DE ANISOL:ETANOL, UNA MEZCLA DE DICLOROMETANO:ETANOL; UTILIZANDO DE 0,9 A 2 EQUIVALENTES DE AMINA EN RELACION AL EPOXIDO; TAMBIEN SE REFIERE A LA PREPARACION DE LA AMINA REACCIONANDO UN ESTER DE 2-HALOPIRIDA Y UNA SAL DE FENOXIDO DE UN ALQUILAMINOFENOL. LOS ESTERES DE ARILOXIPROPANOLAMINA SE PUEDEN CONVERTIR EN AMIDAS DE ARILOXIPROPANOLAMINAS QUE SON UTILES EN EL TRATAMIENTO DE LA OBESIDAD Y DIABETES TIPO II Y COMO ADITIVOS ALIMENTARIOS PARA GANADO PARA PRODUCIR CARNE MAGRA
PE2000001222A 1999-11-15 2000-11-15 Proceso para la preparacion de ariloxipropanolaminas PE20010702A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US16559499P 1999-11-15 1999-11-15

Publications (1)

Publication Number Publication Date
PE20010702A1 true PE20010702A1 (es) 2001-07-07

Family

ID=22599580

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2000001222A PE20010702A1 (es) 1999-11-15 2000-11-15 Proceso para la preparacion de ariloxipropanolaminas

Country Status (3)

Country Link
AU (1) AU1580001A (es)
PE (1) PE20010702A1 (es)
WO (1) WO2001036412A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001036390A1 (en) 1999-11-15 2001-05-25 Eli Lilly And Company Indazolyloxy propanolamines for improving livestock production
US6825220B2 (en) 2000-11-10 2004-11-30 Eli Lilly And Company 3-Substituted oxindole β 3 agonists
ATE340794T1 (de) 2001-08-14 2006-10-15 Lilly Co Eli Indol derivate als beta-3-adrenerge agonisten zur behandlung von typ 2 diabetes
JP2005507872A (ja) 2001-08-14 2005-03-24 イーライ・リリー・アンド・カンパニー 3−置換オキシインドールβ3アゴニスト
EP1448561B1 (en) 2001-11-20 2008-02-20 Eli Lilly And Company Beta 3 adrenergic agonists
ES2242890T3 (es) 2001-11-20 2005-11-16 Eli Lilly And Company Agonistas beta 3 de oxindol 3-sustituido.
WO2003059348A1 (en) 2002-01-11 2003-07-24 Eli Lilly And Company 2-oxo-benzimidazolyl substituted ethanolamine derivatives and their use as beta3 agonists
AU2013327689B2 (en) 2012-10-02 2016-03-17 Eli Lilly And Company Methods for improving chicken production
CN115611752A (zh) * 2022-10-21 2023-01-17 江苏天和制药有限公司 一种卢巴贝隆中间体的合成精制方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH624395A5 (es) * 1976-01-08 1981-07-31 Ciba Geigy Ag
DE2719562C2 (de) * 1976-05-08 1986-05-07 Otsuka Pharmaceutical Co. Ltd., Tokio/Tokyo 3, 4-Dihydrocarbostyrilderivate, Verfahren zu deren Herstellung und Arzneimittel, welche diese enthalten
CH607585A5 (en) * 1976-10-05 1978-09-15 Ciba Geigy Ag Process for the preparation of 2-[3'-(2-(3,4-dimethoxy-phenyl)ethylamino)-2'-hydroxypropoxy]-3-cyanop yridine
DE2830211A1 (de) * 1977-07-21 1979-02-01 Sandoz Ag Substituierte indol-derivate, ihre herstellung und verwendung
KR19990045727A (ko) * 1995-09-21 1999-06-25 피터 지. 스트링거 선택적 β3 아드레날린 효능제
ZA967892B (en) * 1995-09-21 1998-03-18 Lilly Co Eli Selective β3 adrenergic agonists.
ES2171839T3 (es) * 1996-09-05 2002-09-16 Lilly Co Eli Analogos de carbazol como agonistas adrenergicos selectivos de beta3.
US5808080A (en) * 1996-09-05 1998-09-15 Eli Lilly And Company Selective β3 adrenergic agonists
CO5011072A1 (es) * 1997-12-05 2001-02-28 Lilly Co Eli Etanolaminas pirazinil substituidas como agfonistas de los receptores

Also Published As

Publication number Publication date
WO2001036412A1 (en) 2001-05-25
AU1580001A (en) 2001-05-30

Similar Documents

Publication Publication Date Title
US6025516A (en) Resolution of 2-hydroxy-3-amino-3-phenylpropionamide and its conversion to C-13 sidechain of taxanes
RU2009105669A (ru) Способ получения 3-замещенных 2-амино-5-галогенбензамидов
PE20010702A1 (es) Proceso para la preparacion de ariloxipropanolaminas
BRPI0415220A (pt) processo de produção de amida carboxìlica e derivados da mesma
KR840006221A (ko) 트리아졸항 진균제의 제조방법
AR032433A1 (es) Proceso para la preparacion de un isomero de anillo de 5 miembros 3-sustituido y compuestos intermediarios utiles en el mismo
Isowa et al. Synthesis of N δ-Hydroxyornithine
GB962293A (en) New sydnonimines and process for their manufacture
ES2167869T3 (es) Procedimiento para preparar acidos nicotinicos.
US4340603A (en) Novel inotropic prodrugs
CA2127292A1 (en) Process for producing hydroxyalkane carboxylic acid amides
ES2715503T3 (es) Un nuevo método de producción de clorhidrato de nebivolol de alta pureza
AR015924A1 (es) Procedimiento para la preparacion de derivados aminicos de alquiloxi-furanona,compuestos procedentes de este procedimiento, utilizacion de estos compuestosy compuestos intermediarios
EA200200569A1 (ru) Арилоксипропаноламины для улучшения продуктивности домашнего скота
US3758574A (en) N-(aralkyl) malonamide derivatives
ECSP003766A (es) Proceso para la preparacion de ariloxipropanolaminas
US3052684A (en) 4-aryl-4-alkanoyloxy-n-cyano substituted piperidines
KR880007465A (ko) N-(4-피페리딜)벤즈아미드 및 그 염의 제조방법
ES2383861B1 (es) Procedimiento de síntesis de intermedios de crambescidinas, de cimipronidina y de sus derivados.
EA200200721A1 (ru) Производные диазепинкарбоксамида, способ их получения, их применение в качестве лекарственных средств, фармацевтические композиции и их применение
BR0002070A (pt) Processo para preparar 8-ciclopentil-6 etil-3-[substituìdo]-5,8-dihidro-4h-1,2,3a, 7,8-pentaaza-as-indacenos e intermediários úteis no mesmo
GB692265A (en) Improvements in or relating to dichloracetamides
KR940011149B1 (ko) N-아릴알킬 파라아미노에톡시페닐아세트아미드 유도체와 그의 제조방법
JPH02256659A (ja) ジアシルアミド化合物およびアミド類の製造法
CO4650112A1 (es) Compuestos de aminas biciclicas, composiciones que los comprenden y el proceso para su preparacion

Legal Events

Date Code Title Description
FC Refusal